期刊文献+

Association of rs10954213 Polymorphisms and Haplotype Diversity in Interferon Regulatory Factor 5 with Systemic Lupus Erythematosus: A Meta-analysis 被引量:1

Association of rs10954213 Polymorphisms and Haplotype Diversity in Interferon Regulatory Factor 5 with Systemic Lupus Erythematosus: A Meta-analysis
下载PDF
导出
摘要 The rs10954213 polymorphism and the haplotype diversity in interferon regulatory factor 5 (IRF5) play a special role in systemic lupus erythematosus (SLE) but with inconclusive results. We conducted a meta-analysis integrating case-control and haplotype variant studies in multiple ethnic populations to clearly discern the effect of these two variants on SLE. Eleven studies on the relation between rs10954213 polymorpisms in IRF5 and SLE were included and we selected a random effect model to calculate the pooled odds ratios (ORs) and the corresponding 95% confidence interval (95% CI). A total of 6982 cases and 8077 controls were involved in the meta-analysis. The pooled results indicated that A allele was significantly associated with increased risk of SLE as compared with the IRF5 rs10954213 G allele (A vs. G, P<0.00001) in all subjects. The same pattern of the results was also obtained in the European, African American, and Latin American. Asian population had a much lower prevalence of the A allele (49.1%) than any other population studied, and Europeans had the highest frequency of the IRF5 rs10954213 A allele (62.1%). The significant association of increased SLE risk and TCA haplotype was indicated in the contrast of TCA vs. TTA as the pooled OR was 2.14 (P=0.002). The same result was also found in the contrast of TCA vs. TTG as the pooled OR was 1.45 (P=0.004). This meta-analysis suggests that the A allele of rs10954213 and TCA haplotype (rs2004640-rs2070197-rs10954213) in IRF5 is associated with the increased risk of SLE in different ethnic groups, and its prevalence is ethnicity dependent. The rs10954213 polymorphism and the haplotype diversity in interferon regulatory factor 5 (1RF5) play a special role in systemic lupus erythematosus (SLE) but with inconclusive results. We conducted a meta-analysis integrating case-control and haplotype variant studies in multiple ethnic populations to clearly discern the effect of these two variants on SLE. Eleven studies on the relation between rs10954213 polymorpisms in IRF5 and SLE were included and we selected a random effect model to calculate the pooled odds ratios (ORs) and the corresponding 95% confidence interval (95% CI). A total of 6982 cases and 8077 controls were involved in the meta-analysis. The pooled results in- dicated that A allele was significantly associated with increased risk of SLE as compared with the IRF5 rS10954213 G allele (A vs. G, P〈0.00001) in all subjects. The same pattern of the results was also ob- tained in the European, African American, and Latin American. Asian population had a much lower prevalence of the A allele (49.1%) than any other population studied, and Europeans had the highest frequency of the IRF5 rs10954213 A allele (62.1%). The significant association of increased SLE risk and TCA haplotype was indicated in the contrast of TCA vs. TTA as the pooled OR was 2.14 (P=0.002). The same result was also found in the contrast of TCA vs. TTG as the pooled OR was 1.45 (P=-0.004). This meta-analysis suggests that the A allele of rs10954213 and TCA haplotype (rs2004640-rs2070197-rs10954213) in IRF5 is associated with the increased risk of SLE in different ethnic groups, and its prevalence is ethnicity dependent.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2013年第1期15-21,共7页 华中科技大学学报(医学英德文版)
基金 supported by the Program for New Century Excellent Talents from the Ministry of Education of China (No.NCET-09-0390)
关键词 系统性红斑狼疮 调节因子 单倍型 Meta分析 干扰素 多样性 多态性 等位基因频率 gene polymorphism meta-analysis systemic lupus erythematosus interferon regulatory factor 5
  • 相关文献

参考文献1

二级参考文献12

  • 1Baechler EC, Gregersen PK, Behrens TW. The emerging role of interferon in human systemic lupus erythematosus. Curr Opini Immunol, 2004, 16:801-807.
  • 2Banchereau J, Pascual V. Type Ⅰ Interferonin Systemic Lupus Erythematosus and Other Autoimmune Diseases. Immunity, 2006, 25:383-392.
  • 3Patole PS, Pawar RD, Lech M, et al. Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas (Ipr) mice. Nephrol Dial Transplant, 2006, 21:3062-3073.
  • 4Huang Q, Ma Y, Adebayo A, et al. Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis. Arthritis Rheum, 2007, 56:2192-2201.
  • 5Graham RR, Kyogoku C, Sigurdsson S, et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. PNAS, 2007, 104:6758- 6763.
  • 6Armstrong DJ, Crockard AD, Wisdom BG, et al. Accelerated apoptosis in SLE neutrophils cultured with anti-dsDNA antibody isolated from SLE patient serum: a pilot study. Rheumatol Int, 2006, 27 : 153-156.
  • 7Santiago-Raber ML, Baccala R, Haraldsson KM, et al. Theofilopoulos AN : Type- Ⅰ interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med, 2003, 197: 777- 788.
  • 8Bengtsson AA, Sturfelt G, Truedsson L, et al. Activation of type Ⅰ interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus, 2000, 9:664-671.
  • 9Shin HD, Sung YK, Choi CB, et al. Replication of the genetic effects of IFN regulatory factor 5 ( IRF5 ) on systemic lupus erythematosus in a Korean population. Arthritis Research Therapy, 2007, 9 : R32-56.
  • 10De Jager PL, Richardson A, Vyse TJ, et al. Genetic variation in toll-like receptor 9 and susceptibility to systemic lupus erythematosus. Arthritis Rheum, 2006, 54 : 1279- 1282.

共引文献3

同被引文献1

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部